Kairos Pharma Ltd.

KAPA | AMEX

Price Alert Chart Builder DCF Calculator

$1.74

-$0.05 (-2.79%)

Sep 22, 2026, 10:36 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	4.49M	1.27M	93K	437K	73K	14.31K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.09M	1.38M	482K	57K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	896K	38K	8K	n/a	n/a	n/a
Total Current Assets	5.39M	4.17M	101K	437K	73K	14.31K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	62K	222K	382K	542K	702K	n/a
Total Long-Term Assets	1.15M	2.05M	864K	599K	702K	n/a
Total Assets	6.54M	6.22M	965K	1.04M	775K	14.31K
Account Payables	199K	992K	2.4M	1.63M	1.55M	307.15K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	4K	380K	50K
Other Current Liabilities	n/a	n/a	n/a	n/a	14K	n/a
Total Current Liabilities	199K	992K	2.41M	1.63M	1.94M	357.15K
Long-Term Debt	n/a	n/a	638K	582K	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	448K	638K	582K	n/a	n/a
Total Liabilities	199K	1.44M	3.04M	2.22M	1.94M	357.15K
Total Debt	n/a	n/a	638K	586K	380K	50K
Book Value	6.34M	4.78M	-2.08M	-1.18M	-1.17M	-342.84K
Book Value Per Share	2.41	2.94	-1.40	-0.81	-0.64	-0.21
Common Stock	21K	14K	11K	10K	10K	192.39K
Retained Earnings	-14.26M	-8.82M	-6.21M	-4.4M	-3.35M	-1.2M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	6.34M	4.78M	-2.08M	-1.18M	-1.17M	-342.84K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a